nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—CYP2C19—Esomeprazole—Barrett's esophagus	0.297	0.353	CbGbCtD
Norethindrone—CYP2C19—Omeprazole—Barrett's esophagus	0.175	0.208	CbGbCtD
Norethindrone—CYP3A4—Esomeprazole—Barrett's esophagus	0.144	0.171	CbGbCtD
Norethindrone—ABCB1—Omeprazole—Barrett's esophagus	0.141	0.168	CbGbCtD
Norethindrone—CYP3A4—Omeprazole—Barrett's esophagus	0.0848	0.101	CbGbCtD
Norethindrone—Optic neuritis—Esomeprazole—Barrett's esophagus	0.00625	0.0424	CcSEcCtD
Norethindrone—Optic neuritis—Omeprazole—Barrett's esophagus	0.00625	0.0424	CcSEcCtD
Norethindrone—Ethinyl Estradiol—NR1I2—Barrett's esophagus	0.00335	0.78	CrCbGaD
Norethindrone—Photosensitivity—Esomeprazole—Barrett's esophagus	0.00318	0.0215	CcSEcCtD
Norethindrone—Photosensitivity—Omeprazole—Barrett's esophagus	0.00318	0.0215	CcSEcCtD
Norethindrone—Renal impairment—Omeprazole—Barrett's esophagus	0.00293	0.0199	CcSEcCtD
Norethindrone—Renal impairment—Esomeprazole—Barrett's esophagus	0.00293	0.0199	CcSEcCtD
Norethindrone—Purpura—Esomeprazole—Barrett's esophagus	0.0029	0.0196	CcSEcCtD
Norethindrone—Purpura—Omeprazole—Barrett's esophagus	0.0029	0.0196	CcSEcCtD
Norethindrone—Pain in extremity—Omeprazole—Barrett's esophagus	0.00279	0.0189	CcSEcCtD
Norethindrone—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00279	0.0189	CcSEcCtD
Norethindrone—Migraine—Omeprazole—Barrett's esophagus	0.00275	0.0186	CcSEcCtD
Norethindrone—Migraine—Esomeprazole—Barrett's esophagus	0.00275	0.0186	CcSEcCtD
Norethindrone—Breast disorder—Omeprazole—Barrett's esophagus	0.00252	0.0171	CcSEcCtD
Norethindrone—Breast disorder—Esomeprazole—Barrett's esophagus	0.00252	0.0171	CcSEcCtD
Norethindrone—Abdominal distension—Omeprazole—Barrett's esophagus	0.00243	0.0165	CcSEcCtD
Norethindrone—Abdominal distension—Esomeprazole—Barrett's esophagus	0.00243	0.0165	CcSEcCtD
Norethindrone—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.0022	0.0149	CcSEcCtD
Norethindrone—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.0022	0.0149	CcSEcCtD
Norethindrone—Weight increased—Esomeprazole—Barrett's esophagus	0.00219	0.0149	CcSEcCtD
Norethindrone—Weight increased—Omeprazole—Barrett's esophagus	0.00219	0.0149	CcSEcCtD
Norethindrone—Depression—Omeprazole—Barrett's esophagus	0.00214	0.0145	CcSEcCtD
Norethindrone—Depression—Esomeprazole—Barrett's esophagus	0.00214	0.0145	CcSEcCtD
Norethindrone—Renal failure—Omeprazole—Barrett's esophagus	0.00211	0.0143	CcSEcCtD
Norethindrone—Renal failure—Esomeprazole—Barrett's esophagus	0.00211	0.0143	CcSEcCtD
Norethindrone—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00203	0.0138	CcSEcCtD
Norethindrone—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00203	0.0138	CcSEcCtD
Norethindrone—Hepatitis—Esomeprazole—Barrett's esophagus	0.00193	0.0131	CcSEcCtD
Norethindrone—Hepatitis—Omeprazole—Barrett's esophagus	0.00193	0.0131	CcSEcCtD
Norethindrone—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.0019	0.0129	CcSEcCtD
Norethindrone—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.0019	0.0129	CcSEcCtD
Norethindrone—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.00183	0.0124	CcSEcCtD
Norethindrone—Erythema multiforme—Omeprazole—Barrett's esophagus	0.00183	0.0124	CcSEcCtD
Norethindrone—Immune system disorder—Omeprazole—Barrett's esophagus	0.00174	0.0118	CcSEcCtD
Norethindrone—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00174	0.0118	CcSEcCtD
Norethindrone—Alopecia—Esomeprazole—Barrett's esophagus	0.00171	0.0116	CcSEcCtD
Norethindrone—Alopecia—Omeprazole—Barrett's esophagus	0.00171	0.0116	CcSEcCtD
Norethindrone—Mental disorder—Esomeprazole—Barrett's esophagus	0.00169	0.0115	CcSEcCtD
Norethindrone—Mental disorder—Omeprazole—Barrett's esophagus	0.00169	0.0115	CcSEcCtD
Norethindrone—Flatulence—Esomeprazole—Barrett's esophagus	0.00166	0.0112	CcSEcCtD
Norethindrone—Flatulence—Omeprazole—Barrett's esophagus	0.00166	0.0112	CcSEcCtD
Norethindrone—Tension—Omeprazole—Barrett's esophagus	0.00165	0.0112	CcSEcCtD
Norethindrone—Tension—Esomeprazole—Barrett's esophagus	0.00165	0.0112	CcSEcCtD
Norethindrone—Nervousness—Esomeprazole—Barrett's esophagus	0.00163	0.0111	CcSEcCtD
Norethindrone—Nervousness—Omeprazole—Barrett's esophagus	0.00163	0.0111	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00142	0.00963	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00142	0.00963	CcSEcCtD
Norethindrone—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00137	0.0093	CcSEcCtD
Norethindrone—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00137	0.0093	CcSEcCtD
Norethindrone—Skin disorder—Esomeprazole—Barrett's esophagus	0.00133	0.00903	CcSEcCtD
Norethindrone—Skin disorder—Omeprazole—Barrett's esophagus	0.00133	0.00903	CcSEcCtD
Norethindrone—Insomnia—Omeprazole—Barrett's esophagus	0.00124	0.00841	CcSEcCtD
Norethindrone—Insomnia—Esomeprazole—Barrett's esophagus	0.00124	0.00841	CcSEcCtD
Norethindrone—Somnolence—Esomeprazole—Barrett's esophagus	0.00122	0.00827	CcSEcCtD
Norethindrone—Somnolence—Omeprazole—Barrett's esophagus	0.00122	0.00827	CcSEcCtD
Norethindrone—Dyspepsia—Omeprazole—Barrett's esophagus	0.00121	0.00818	CcSEcCtD
Norethindrone—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00121	0.00818	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00118	0.00803	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00118	0.00803	CcSEcCtD
Norethindrone—Fatigue—Esomeprazole—Barrett's esophagus	0.00118	0.00802	CcSEcCtD
Norethindrone—Fatigue—Omeprazole—Barrett's esophagus	0.00118	0.00802	CcSEcCtD
Norethindrone—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00112	0.0076	CcSEcCtD
Norethindrone—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00112	0.0076	CcSEcCtD
Norethindrone—Urticaria—Omeprazole—Barrett's esophagus	0.00109	0.00739	CcSEcCtD
Norethindrone—Urticaria—Esomeprazole—Barrett's esophagus	0.00109	0.00739	CcSEcCtD
Norethindrone—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00108	0.00735	CcSEcCtD
Norethindrone—Abdominal pain—Omeprazole—Barrett's esophagus	0.00108	0.00735	CcSEcCtD
Norethindrone—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00101	0.00685	CcSEcCtD
Norethindrone—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00101	0.00685	CcSEcCtD
Norethindrone—Asthenia—Omeprazole—Barrett's esophagus	0.000984	0.00667	CcSEcCtD
Norethindrone—Asthenia—Esomeprazole—Barrett's esophagus	0.000984	0.00667	CcSEcCtD
Norethindrone—Pruritus—Esomeprazole—Barrett's esophagus	0.00097	0.00658	CcSEcCtD
Norethindrone—Pruritus—Omeprazole—Barrett's esophagus	0.00097	0.00658	CcSEcCtD
Norethindrone—Drospirenone—PTGS2—Barrett's esophagus	0.000945	0.22	CrCbGaD
Norethindrone—Dizziness—Omeprazole—Barrett's esophagus	0.000907	0.00615	CcSEcCtD
Norethindrone—Dizziness—Esomeprazole—Barrett's esophagus	0.000907	0.00615	CcSEcCtD
Norethindrone—Vomiting—Esomeprazole—Barrett's esophagus	0.000872	0.00591	CcSEcCtD
Norethindrone—Vomiting—Omeprazole—Barrett's esophagus	0.000872	0.00591	CcSEcCtD
Norethindrone—Rash—Omeprazole—Barrett's esophagus	0.000865	0.00586	CcSEcCtD
Norethindrone—Rash—Esomeprazole—Barrett's esophagus	0.000865	0.00586	CcSEcCtD
Norethindrone—Dermatitis—Omeprazole—Barrett's esophagus	0.000864	0.00586	CcSEcCtD
Norethindrone—Dermatitis—Esomeprazole—Barrett's esophagus	0.000864	0.00586	CcSEcCtD
Norethindrone—Headache—Esomeprazole—Barrett's esophagus	0.000859	0.00582	CcSEcCtD
Norethindrone—Headache—Omeprazole—Barrett's esophagus	0.000859	0.00582	CcSEcCtD
Norethindrone—Nausea—Esomeprazole—Barrett's esophagus	0.000815	0.00552	CcSEcCtD
Norethindrone—Nausea—Omeprazole—Barrett's esophagus	0.000815	0.00552	CcSEcCtD
Norethindrone—PGR—Nuclear Receptors—NR1I2—Barrett's esophagus	0.000444	0.0824	CbGpPWpGaD
Norethindrone—ALB—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.000414	0.0767	CbGpPWpGaD
Norethindrone—PGR—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.000351	0.0651	CbGpPWpGaD
Norethindrone—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000263	0.0487	CbGpPWpGaD
Norethindrone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000176	0.0326	CbGpPWpGaD
Norethindrone—CYP3A7—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000173	0.0321	CbGpPWpGaD
Norethindrone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000162	0.03	CbGpPWpGaD
Norethindrone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000151	0.028	CbGpPWpGaD
Norethindrone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000151	0.028	CbGpPWpGaD
Norethindrone—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00015	0.0278	CbGpPWpGaD
Norethindrone—PGR—Nuclear Receptors—PPARG—Barrett's esophagus	0.000146	0.0271	CbGpPWpGaD
Norethindrone—CYP3A7—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000142	0.0264	CbGpPWpGaD
Norethindrone—CYP3A5—Irinotecan Pathway—APC—Barrett's esophagus	0.000139	0.0257	CbGpPWpGaD
Norethindrone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000127	0.0235	CbGpPWpGaD
Norethindrone—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000125	0.0232	CbGpPWpGaD
Norethindrone—PGR—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.000116	0.0214	CbGpPWpGaD
Norethindrone—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000103	0.0191	CbGpPWpGaD
Norethindrone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	9.81e-05	0.0182	CbGpPWpGaD
Norethindrone—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	9.7e-05	0.018	CbGpPWpGaD
Norethindrone—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	9.68e-05	0.018	CbGpPWpGaD
Norethindrone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	9.29e-05	0.0172	CbGpPWpGaD
Norethindrone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	9.29e-05	0.0172	CbGpPWpGaD
Norethindrone—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	7.95e-05	0.0148	CbGpPWpGaD
Norethindrone—CYP3A7—Biological oxidations—CYP26A1—Barrett's esophagus	7.56e-05	0.014	CbGpPWpGaD
Norethindrone—CYP3A7—Metapathway biotransformation—CYP26A1—Barrett's esophagus	7.45e-05	0.0138	CbGpPWpGaD
Norethindrone—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	6.44e-05	0.012	CbGpPWpGaD
Norethindrone—PGR—Generic Transcription Pathway—NR1I2—Barrett's esophagus	6.06e-05	0.0113	CbGpPWpGaD
Norethindrone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	5.9e-05	0.0109	CbGpPWpGaD
Norethindrone—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	5.82e-05	0.0108	CbGpPWpGaD
Norethindrone—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	5.46e-05	0.0101	CbGpPWpGaD
Norethindrone—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	5.39e-05	0.01	CbGpPWpGaD
Norethindrone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	4.96e-05	0.00921	CbGpPWpGaD
Norethindrone—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	4.78e-05	0.00887	CbGpPWpGaD
Norethindrone—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	4.22e-05	0.00784	CbGpPWpGaD
Norethindrone—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	4.17e-05	0.00773	CbGpPWpGaD
Norethindrone—ALB—Platelet degranulation—HGF—Barrett's esophagus	3.99e-05	0.00739	CbGpPWpGaD
Norethindrone—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	3.8e-05	0.00704	CbGpPWpGaD
Norethindrone—ALB—Vitamin B12 Metabolism—RELA—Barrett's esophagus	3.31e-05	0.00615	CbGpPWpGaD
Norethindrone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	3.06e-05	0.00567	CbGpPWpGaD
Norethindrone—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	2.94e-05	0.00545	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—NR1I2—Barrett's esophagus	2.92e-05	0.00542	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—RELA—Barrett's esophagus	2.7e-05	0.005	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	2.54e-05	0.00471	CbGpPWpGaD
Norethindrone—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	2.5e-05	0.00465	CbGpPWpGaD
Norethindrone—ALB—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	2.44e-05	0.00452	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	2.38e-05	0.00442	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—RELA—Barrett's esophagus	2.14e-05	0.00397	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	2.14e-05	0.00397	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	2.08e-05	0.00386	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	2.02e-05	0.00375	CbGpPWpGaD
Norethindrone—PGR—Generic Transcription Pathway—PPARG—Barrett's esophagus	2e-05	0.0037	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	1.93e-05	0.00358	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—GAST—Barrett's esophagus	1.78e-05	0.00331	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	1.77e-05	0.00328	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	1.77e-05	0.00328	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTGES—Barrett's esophagus	1.71e-05	0.00316	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—TP53—Barrett's esophagus	1.56e-05	0.00289	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	1.29e-05	0.0024	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYP26A1—Barrett's esophagus	1.29e-05	0.0024	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	1.24e-05	0.0023	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTGES—Barrett's esophagus	1.23e-05	0.00229	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—SST—Barrett's esophagus	1.22e-05	0.00227	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	1.09e-05	0.00201	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTGES—Barrett's esophagus	1.06e-05	0.00197	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	9.81e-06	0.00182	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—PPARG—Barrett's esophagus	9.61e-06	0.00178	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGES—Barrett's esophagus	9.53e-06	0.00177	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	9.34e-06	0.00173	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—SLC9A1—Barrett's esophagus	9.32e-06	0.00173	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGES—Barrett's esophagus	9.3e-06	0.00173	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—HGF—Barrett's esophagus	9.11e-06	0.00169	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP26A1—Barrett's esophagus	8.05e-06	0.00149	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	7.22e-06	0.00134	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	7.05e-06	0.00131	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	6.73e-06	0.00125	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—APC—Barrett's esophagus	6.47e-06	0.0012	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	5.95e-06	0.0011	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	5.84e-06	0.00108	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SLC9A1—Barrett's esophagus	5.8e-06	0.00108	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGES—Barrett's esophagus	5.73e-06	0.00106	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	5.34e-06	0.00099	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	5.21e-06	0.000966	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	5.08e-06	0.000943	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—RELA—Barrett's esophagus	5.06e-06	0.000938	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CXCL8—Barrett's esophagus	4.77e-06	0.000884	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.68e-06	0.000868	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	4.34e-06	0.000806	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PPARG—Barrett's esophagus	4.25e-06	0.000789	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.2e-06	0.000779	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTGS2—Barrett's esophagus	3.35e-06	0.000621	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	3.13e-06	0.000581	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARG—Barrett's esophagus	3.07e-06	0.00057	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TP53—Barrett's esophagus	3.06e-06	0.000567	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TP53—Barrett's esophagus	2.92e-06	0.000543	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARG—Barrett's esophagus	2.65e-06	0.000491	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	2.42e-06	0.000449	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARG—Barrett's esophagus	2.38e-06	0.000441	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARG—Barrett's esophagus	2.32e-06	0.00043	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTGS2—Barrett's esophagus	2.08e-06	0.000386	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	1.87e-06	0.000347	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGS2—Barrett's esophagus	1.82e-06	0.000339	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARG—Barrett's esophagus	1.43e-06	0.000265	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	1.12e-06	0.000209	CbGpPWpGaD
